BioSpace News Archive

Drug Development

PharmaCyte’s Clinical Trial in Pancreatic Cancer Serves as Proving Ground for Its One of a Kind Cell Encapsulation Technology

PharmaCyte Biotech, Inc. (OTCQB: PMCB) is closing in on what will be a landmark event in this small company’s history—a clinical trial in the United States under the watchful eye of the most powerful drug regulatory agency in the world

July 5, 2018
·
7 min read
Deals

Avid Bioservices Declares Quarterly Dividend on Its Series E Convertible Preferred Stock

Avid Bioservices, Inc. announced that its Board of Directors has declared a quarterly cash dividend payment on the Company’s 10.50% Series E Convertible Preferred Stock (the “Series E Preferred Stock”).

July 5, 2018
·
1 min read
Deals

Madrigal Pharmaceuticals Prices Public Offering of Common Stock

Madrigal Pharmaceuticals, Inc. announced the pricing of an underwritten registered public offering of 1,347,232 shares of its common stock at a public offering price of $305.00 per share.

July 5, 2018
·
4 min read
Business

Amarantus Provides Update on Elto Pharma Capital Formation Plan

Amarantus Bioscience Holdings, Inc. provided an update to the marketplace on its capital formation plans for its wholly-owned subsidiary Elto Pharma, Inc.

July 5, 2018
·
4 min read
Business

Arbutus Strengthens Management Team With Appointment of David C. Hastings as New Chief Financial Officer

Arbutus Biopharma Corporation announced the appointment of David Hastings as Chief Financial Officer, effective June 11, 2018.

July 5, 2018
·
4 min read
Business

The American Health Council Selects Ruth Dapaah-Afriyie, Pharm.D., B.Pharm., BCACP, CDOE, CVDOE to Industry Board

The American Health Council selected Ruth Dapaah-Afriyie, Pharm.D., B.Pharm., BCACP, CDOE, CVDOE to its Industry Board.

July 5, 2018
·
5 min read
Drug Development

International Stem Cell Corporation Doses First Patient of the Third Cohort in Parkinson’s Disease Clinical Trial

International Stem Cell Corporation announced that the first patient of the third cohort of the clinical trial for Parkinson’s disease was successfully transplanted with 70,000,000 ISC-hpNSC®.

July 5, 2018
·
7 min read
BioCapital

Kansas University Medical Center and iSage Rx Receive Blue Cross and Blue Shield of Kansas City (Blue KC) Outcomes Grant to Study Insulin Optimization

Insulin-Dependent Patients Will Be Enrolled in Clinical Trial Using iSage’s FDA Cleared Insulin Titration Application

July 5, 2018
·
3 min read
Pharm Country

Three High Profile Publications Support the Potential of Protagenic Therapeutics’s Synthetic TCAP to Treat Stress-Related Psychological Disorders

Ancient, central role of brain peptide TCAP in maintenance of brain health elucidated in publications in Cell, Nature Communications, and the Journal of Neuro-endocrinology

July 5, 2018
·
6 min read
Business

Easton Pharmaceuticals Announces That Easton and Its JV Partner, Alliance Group, Have Generated $40,000 in Revenues in the First Week of Operations

Operations are Anticipated to Continually Increase, Which Includes Volume and Pricing, While it Prepares to Launch Its More Profitable Aggregate Operations

July 5, 2018
·
3 min read